Amount$15M
Post-money valuation$55M
AnnouncedDec 18, 1998
SectorOncology, Immunology, Life Sciences
Solid
A solid round with healthy fundamentals.
Syndicate size
Healthy syndicate of 4 investors.
Insider conviction
4 existing investors re-upped — insiders doubling down.
Investor track record
Mostly newer or unproven managers.
Heuristic read of round size vs peers, syndicate size, insider conviction, and investor track record. Not investment advice.
vs. Oncology, Immunology, Life Sciences (5)
Round size in sector40th pct
$12Mthis round: $15M$20M
